Web Stats Provided By Google Analytics

Tuesday, January 21, 2014

Teva Expands CNS Specialty Business with Acquisition of NuPathe

Teva Pharmaceutical Industries Ltd. today announced that it has entered into a definitive agreement under which Teva will acquire NuPathe Inc. for $3.65 per share in cash, or approximately $144 million.

http://ift.tt/KyveuF

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts